Literature DB >> 22906279

Immunohistochemical investigation of the correlation between LIM kinase 1 expression and development and progression of human ovarian carcinoma.

W Zhang1, N Gan, J Zhou.   

Abstract

OBJECTIVES: LIM kinase 1 (LIMK1) is implicated in cellular mechanisms regulating tumour cell invasion and may be involved in ovarian carcinoma progression. This retrospective study, therefore, investigated expression of the LIMK1 gene in primary ovarian tumour tissue samples and evaluated the correlation between LIMK1 gene expression and progression of ovarian carcinoma.
METHODS: LIMK1 protein levels were detected by immunohistochemistry in ovarian tissue samples from 57 patients with primary ovarian epithelial tumours (benign, n = 13; borderline, n = 14; carcinoma, n = 30) and 10 patients with normal ovaries. LIMK1 protein levels were evaluated by calculating the product of the scores for stain intensity and percentage of cells stained.
RESULTS: There was a significant correlation between increasing LIMK1 protein levels and increasing disease severity, from normal ovarian tissues through benign and borderline tumours to ovarian carcinoma. There was also a significant correlation between increasing LIMK1 protein levels and increasingly poor levels of differentiation of ovarian carcinoma.
CONCLUSIONS: LIMK1 is associated with the development of ovarian cancer and with the level of tumour differentiation in patients with ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906279     DOI: 10.1177/147323001204000325

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

1.  LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.

Authors:  Xin Liu; Qiang Song; Daohan Wang; Yubiao Liu; Zhixiang Zhang; Weihua Fu
Journal:  Oncol Lett       Date:  2022-05-30       Impact factor: 3.111

2.  MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.

Authors:  Jianda Zhou; Rui Liu; Chengqun Luo; Xiao Zhou; Kun Xia; Xiang Chen; Ming Zhou; Qiong Zou; Peiguo Cao; Ke Cao
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

3.  Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.

Authors:  Jin-Bei Huang; Yu-Peng Wu; Yun-Zhi Lin; Hai Cai; Shao-Hao Chen; Xiong-Lin Sun; Xiao-Dong Li; Yong Wei; Qing-Shui Zheng; Ning Xu; Xue-Yi Xue
Journal:  J Cell Mol Med       Date:  2020-03-13       Impact factor: 5.310

4.  Alantolactone suppresses the metastatic phenotype and induces the apoptosis of glioblastoma cells by targeting LIMK kinase activity and activating the cofilin/G‑actin signaling cascade.

Authors:  Xun Wang; Shuang Zou; Tong Ren; Li-Jun Zhao; Li-Fei Yu; Xiang-Yu Li; Xin Yan; Li-Jun Zhang
Journal:  Int J Mol Med       Date:  2021-03-02       Impact factor: 4.101

5.  Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Guojun Lu; Ying Zhou; Chenxi Zhang; Yu Zhang
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.